EU Medicines Agency Ditches X, Moves to Bluesky Amidst Musk Controversy
The European Medicines Agency (EMA) has abandoned X, formerly known as Twitter, and moved its communications to Bluesky. This decision reflects a growing unease with Elon Musk’s ownership and direction of the platform, and a desire for a more reliable and less politically charged environment for disseminating crucial health information.
The EMA’s departure isn’t simply a shift to a new social media platform; it’s a strategic move signaling a lack of confidence in X’s ability to consistently deliver vital public health messages. The agency clearly feels it can no longer depend on X as a dependable means of reaching the public with essential information, potentially impacting citizens who rely on the platform for updates on medications and medical decisions.… Continue reading
Matt Underwood 
John Q. Hosedrinker